Bylinkina V S, Golubeva N V, Gureeva T A, Lokshina L A, Polianskaia A M, Samoĭlova R S
Vopr Med Khim. 1991 Nov-Dec;37(6):30-3.
Activities of dipeptidyl-aminopeptidase IV, urokinase-like plasminogen activator, cathepsins B and L were studied in lymphoid cells of patients with various forms of lymphoproliferative disorders. Activity of the enzymes studied was found in all the T- and B-cell, although rate and ratio of the enzymatic activity were dissimilar in various cell types. The highest rate of activity exhibited cells at early stages of maturation obtained from patients with acute lymphoblastic leukemia, while low level of the proteinase activity was detected in cells of patients with chronic lymphoid leukemia, non-Hodgkin lymphoma, hairy cell leukemia and Sezary disease, corresponding to mature T- and B-subpopulations. As shown by analysis of the cells immunological phenotype and their proteolytic activity, the rate of lymphoid cells differentiation correlated with level of proteinases activity. Series of proteinases were firstly studied in human malignant lymphoid cells with known phenotype. The enzyme assay may be used in diagnosis and treatment of patients with lymphoproliferative disorders.
研究了不同形式淋巴增殖性疾病患者淋巴细胞中二肽基氨基肽酶IV、尿激酶型纤溶酶原激活剂、组织蛋白酶B和L的活性。在所研究的所有T细胞和B细胞中均发现了这些酶的活性,尽管酶活性的速率和比例在不同细胞类型中有所不同。急性淋巴细胞白血病患者成熟早期的细胞表现出最高的活性速率,而在慢性淋巴细胞白血病、非霍奇金淋巴瘤、毛细胞白血病和Sezary病患者的细胞中检测到较低水平的蛋白酶活性,这些细胞对应于成熟的T细胞和B细胞亚群。通过对细胞免疫表型及其蛋白水解活性的分析表明,淋巴细胞分化速率与蛋白酶活性水平相关。首次在具有已知表型的人类恶性淋巴细胞中研究了一系列蛋白酶。酶活性测定可用于淋巴增殖性疾病患者的诊断和治疗。